 |
인쇄하기
취소
|
Samchundang Pharm to induce nifedipine sustained-release formulation technology
Samchundang Pharm said on April 6 that it will induce nifedipine sustained-release formulation technology under a contract with the Korea Research Institute of Chemical and Technology.
Under the contract, Samchundang is to pay the KRICT 100 milllion won in down payments plus running royalty covering 1.5 percent of gross sales every year.
The company said that such formulation technology, ...
Under the contract, Samchundang is to pay the KRICT 100 milllion won in down payments plus running royalty covering 1.5 percent of gross sales every year.
The company said that such formulation technology, ...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.